Molecular dynamics-based insight of VEGFR-2 kinase domain: a combined study of pharmacophore modeling and molecular docking and dynamics

被引:0
作者
Md. Rimon Parves
Yasir Mohamed Riza
Sanjida Alam
Sadia Jaman
机构
[1] University of Science and Technology Chittagong (USTC),Department of Biochemistry and Biotechnology, Faculty of Basic Medical and Pharmaceutical Sciences
[2] Jagannath University,Department of Genetic Engineering & Biotechnology
来源
Journal of Molecular Modeling | 2023年 / 29卷
关键词
VEGFR-2; Pharmacophore modeling; QM/MM; Molecular dynamics simulation; DFT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 142 条
[1]  
Holmes K(2007)Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition Cell Signal 19 2003-2012
[2]  
Roberts OL(2006)Vascular endothelial growth factor signaling pathways: therapeutic perspective Clin Cancer Res 12 5018-5022
[3]  
Thomas AM(2006)Biology of vascular endothelial growth factors FEBS Lett 580 2879-2887
[4]  
Cross MJ(2011)Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies Genes Cancer 2 1097-1105
[5]  
Kowanetz M(2006)The role of VEGF receptors in angiogenesis; complex partnerships Cell Mol Life Sci 63 601-286
[6]  
Ferrara N(2008)Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis BMB Rep 41 278-3627
[7]  
Roy H(2010)Angiopoietin-2 interferes with anti-VEGFR2–induced vessel normalization and survival benefit in mice bearing gliomas Clin Cancer Res 16 3618-2146
[8]  
Bhardwaj S(2000)Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells Oncogene 19 2138-279
[9]  
Ylä-Herttuala S(2012)Rate of serious adverse effects in a series of bevacizumab and ranibizumab injections Can J Ophthalmol 47 275-611
[10]  
Shibuya M(2004)Vascular endothelial growth factor: basic science and clinical progress Endocr Rev 25 581-243